These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 23834691)
1. Multimarker approach for identifying and documenting mitigation of cardiovascular risk. Penn MS; Klemes AB Future Cardiol; 2013 Jul; 9(4):497-506. PubMed ID: 23834691 [TBL] [Abstract][Full Text] [Related]
2. Prediction of cardiovascular disease events. Wilson PW Cardiol Clin; 2011 Feb; 29(1):1-13. PubMed ID: 21257097 [TBL] [Abstract][Full Text] [Related]
3. Putting it into perspective: multimarker panels for cardiovascular disease risk assessment. Taqui S; Daniels LB Biomark Med; 2013 Apr; 7(2):317-27. PubMed ID: 23547825 [TBL] [Abstract][Full Text] [Related]
4. Multiple biomarkers for the prediction of first major cardiovascular events and death. Wang TJ; Gona P; Larson MG; Tofler GH; Levy D; Newton-Cheh C; Jacques PF; Rifai N; Selhub J; Robins SJ; Benjamin EJ; D'Agostino RB; Vasan RS N Engl J Med; 2006 Dec; 355(25):2631-9. PubMed ID: 17182988 [TBL] [Abstract][Full Text] [Related]
7. C-reactive protein: a novel marker of cardiovascular risk. Shah SH; Newby LK Cardiol Rev; 2003; 11(4):169-79. PubMed ID: 12852794 [TBL] [Abstract][Full Text] [Related]
8. Multimarker strategy for short-term risk assessment in patients with dyspnea in the emergency department: the MARKED (Multi mARKer Emergency Dyspnea)-risk score. Eurlings LW; Sanders-van Wijk S; van Kimmenade R; Osinski A; van Helmond L; Vallinga M; Crijns HJ; van Dieijen-Visser MP; Brunner-La Rocca HP; Pinto YM J Am Coll Cardiol; 2012 Oct; 60(17):1668-77. PubMed ID: 23021334 [TBL] [Abstract][Full Text] [Related]
9. Perceptions of Canadian primary care physicians towards cardiovascular risk assessment and lipid management. Gupta M; Singh N; Tsigoulis M; Kajil M; Hirjikaka S; Quan A; Teoh H; Verma S Can J Cardiol; 2012; 28(1):14-9. PubMed ID: 22264843 [TBL] [Abstract][Full Text] [Related]
10. Beyond the Limits: Clinical Utility of Novel Cardiac Biomarkers. Janković R; Marković D; Savić N; Dinić V Biomed Res Int; 2015; 2015():187384. PubMed ID: 26504786 [TBL] [Abstract][Full Text] [Related]
11. Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis. Koenig W Ann Med; 2009; 41(5):332-43. PubMed ID: 19291518 [TBL] [Abstract][Full Text] [Related]
13. Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study. von Eynatten M; Breitling LP; Roos M; Baumann M; Rothenbacher D; Brenner H Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2327-35. PubMed ID: 22679309 [TBL] [Abstract][Full Text] [Related]
14. Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study. Ingelsson E; Pencina MJ; Tofler GH; Benjamin EJ; Lanier KJ; Jacques PF; Fox CS; Meigs JB; Levy D; Larson MG; Selhub J; D'Agostino RB; Wang TJ; Vasan RS Circulation; 2007 Aug; 116(9):984-92. PubMed ID: 17698726 [TBL] [Abstract][Full Text] [Related]